nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—GUCY1B3—tongue—epilepsy syndrome	0.0113	0.0719	CbGeAlD
Nitroglycerin—NPR1—hindbrain—epilepsy syndrome	0.00809	0.0516	CbGeAlD
Nitroglycerin—GUCY1B3—forebrain—epilepsy syndrome	0.00478	0.0305	CbGeAlD
Nitroglycerin—NPR1—brainstem—epilepsy syndrome	0.00464	0.0295	CbGeAlD
Nitroglycerin—NPR1—forebrain—epilepsy syndrome	0.00447	0.0285	CbGeAlD
Nitroglycerin—GUCY1A3—telencephalon—epilepsy syndrome	0.00443	0.0282	CbGeAlD
Nitroglycerin—GUCY1B3—telencephalon—epilepsy syndrome	0.0044	0.028	CbGeAlD
Nitroglycerin—GUCY1A2—head—epilepsy syndrome	0.00438	0.0279	CbGeAlD
Nitroglycerin—GUCY1A2—nervous system—epilepsy syndrome	0.00415	0.0265	CbGeAlD
Nitroglycerin—NPR1—telencephalon—epilepsy syndrome	0.00411	0.0262	CbGeAlD
Nitroglycerin—ALDH2—forebrain—epilepsy syndrome	0.00406	0.0259	CbGeAlD
Nitroglycerin—GUCY1A2—central nervous system—epilepsy syndrome	0.004	0.0255	CbGeAlD
Nitroglycerin—GUCY1A2—cerebellum—epilepsy syndrome	0.00391	0.0249	CbGeAlD
Nitroglycerin—ALDH2—telencephalon—epilepsy syndrome	0.00373	0.0238	CbGeAlD
Nitroglycerin—GUCY1A3—medulla oblongata—epilepsy syndrome	0.00348	0.0222	CbGeAlD
Nitroglycerin—GUCY1B3—medulla oblongata—epilepsy syndrome	0.00346	0.022	CbGeAlD
Nitroglycerin—NPR1—medulla oblongata—epilepsy syndrome	0.00323	0.0206	CbGeAlD
Nitroglycerin—GUCY1A3—midbrain—epilepsy syndrome	0.00318	0.0203	CbGeAlD
Nitroglycerin—GUCY1A2—brain—epilepsy syndrome	0.00317	0.0202	CbGeAlD
Nitroglycerin—GUCY1B3—midbrain—epilepsy syndrome	0.00316	0.0201	CbGeAlD
Nitroglycerin—GUCY1A3—spinal cord—epilepsy syndrome	0.0031	0.0198	CbGeAlD
Nitroglycerin—GUCY1B3—spinal cord—epilepsy syndrome	0.00308	0.0196	CbGeAlD
Nitroglycerin—NPR1—midbrain—epilepsy syndrome	0.00295	0.0188	CbGeAlD
Nitroglycerin—ALDH2—medulla oblongata—epilepsy syndrome	0.00293	0.0187	CbGeAlD
Nitroglycerin—NPR1—spinal cord—epilepsy syndrome	0.00288	0.0184	CbGeAlD
Nitroglycerin—GUCY1A3—head—epilepsy syndrome	0.00276	0.0176	CbGeAlD
Nitroglycerin—GUCY1B3—head—epilepsy syndrome	0.00274	0.0175	CbGeAlD
Nitroglycerin—ALDH2—midbrain—epilepsy syndrome	0.00268	0.0171	CbGeAlD
Nitroglycerin—ALDH2—spinal cord—epilepsy syndrome	0.00262	0.0167	CbGeAlD
Nitroglycerin—GUCY1A3—nervous system—epilepsy syndrome	0.00262	0.0167	CbGeAlD
Nitroglycerin—GUCY1B3—nervous system—epilepsy syndrome	0.0026	0.0166	CbGeAlD
Nitroglycerin—NPR1—head—epilepsy syndrome	0.00256	0.0163	CbGeAlD
Nitroglycerin—GUCY1A3—central nervous system—epilepsy syndrome	0.00252	0.0161	CbGeAlD
Nitroglycerin—GUCY1B3—central nervous system—epilepsy syndrome	0.0025	0.0159	CbGeAlD
Nitroglycerin—GUCY1A3—cerebellum—epilepsy syndrome	0.00246	0.0157	CbGeAlD
Nitroglycerin—GUCY1B3—cerebellum—epilepsy syndrome	0.00244	0.0156	CbGeAlD
Nitroglycerin—NPR1—nervous system—epilepsy syndrome	0.00243	0.0155	CbGeAlD
Nitroglycerin—NPR1—central nervous system—epilepsy syndrome	0.00234	0.0149	CbGeAlD
Nitroglycerin—ALDH2—head—epilepsy syndrome	0.00233	0.0148	CbGeAlD
Nitroglycerin—NPR1—cerebellum—epilepsy syndrome	0.00229	0.0146	CbGeAlD
Nitroglycerin—ALDH2—nervous system—epilepsy syndrome	0.00221	0.0141	CbGeAlD
Nitroglycerin—ALDH2—central nervous system—epilepsy syndrome	0.00212	0.0135	CbGeAlD
Nitroglycerin—ALDH2—cerebellum—epilepsy syndrome	0.00207	0.0132	CbGeAlD
Nitroglycerin—GUCY1A3—brain—epilepsy syndrome	0.002	0.0127	CbGeAlD
Nitroglycerin—GUCY1B3—brain—epilepsy syndrome	0.00199	0.0127	CbGeAlD
Nitroglycerin—NPR1—brain—epilepsy syndrome	0.00186	0.0118	CbGeAlD
Nitroglycerin—ALDH2—brain—epilepsy syndrome	0.00169	0.0107	CbGeAlD
Nitroglycerin—ALDH2—Neuronal System—KCNC1—epilepsy syndrome	0.00152	0.00566	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—CACNG2—epilepsy syndrome	0.00151	0.0056	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—DOCK7—epilepsy syndrome	0.00147	0.00546	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—SLC8A1—epilepsy syndrome	0.00145	0.00539	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—CHRNA2—epilepsy syndrome	0.00142	0.00526	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNAB2—epilepsy syndrome	0.00136	0.00505	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCND2—epilepsy syndrome	0.00136	0.00505	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—CACNB4—epilepsy syndrome	0.00134	0.00499	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—CACNA2D2—epilepsy syndrome	0.00134	0.00499	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—LAMP2—epilepsy syndrome	0.00134	0.00499	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—LAMP2—epilepsy syndrome	0.00134	0.00499	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GABRG2—epilepsy syndrome	0.00128	0.00476	CbGpPWpGaD
Nitroglycerin—ALDH2—Tryptophan metabolism—CAT—epilepsy syndrome	0.00125	0.00463	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNK3—epilepsy syndrome	0.00124	0.00461	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNK9—epilepsy syndrome	0.00124	0.00461	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GRIK5—epilepsy syndrome	0.00124	0.00461	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CACNG3—epilepsy syndrome	0.00124	0.00461	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.00124	0.00461	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.00123	0.00459	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—LAMP2—epilepsy syndrome	0.0012	0.00445	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—HCN1—epilepsy syndrome	0.00115	0.00429	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNV1—epilepsy syndrome	0.00115	0.00429	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CACNG2—epilepsy syndrome	0.00115	0.00429	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.00111	0.00414	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—SLC8A2—epilepsy syndrome	0.00111	0.00413	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—SLC8A2—epilepsy syndrome	0.00111	0.00413	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ATP2A2—epilepsy syndrome	0.00111	0.00413	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ACTB—epilepsy syndrome	0.0011	0.00408	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNQ2—epilepsy syndrome	0.00109	0.00403	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CHRNA2—epilepsy syndrome	0.00109	0.00403	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNQ3—epilepsy syndrome	0.00109	0.00403	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—NSF—epilepsy syndrome	0.00107	0.00399	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—SYN1—epilepsy syndrome	0.00107	0.00399	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—OXT—epilepsy syndrome	0.00107	0.00399	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—CRH—epilepsy syndrome	0.00107	0.00399	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—SLC8A3—epilepsy syndrome	0.00106	0.00394	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—SLC8A3—epilepsy syndrome	0.00106	0.00394	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—STXBP1—epilepsy syndrome	0.00104	0.00388	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Platelet homeostasis—NOS2—epilepsy syndrome	0.00103	0.00383	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Platelet homeostasis—NOS2—epilepsy syndrome	0.00103	0.00383	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNB1—epilepsy syndrome	0.00103	0.00382	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CACNB4—epilepsy syndrome	0.00103	0.00382	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CACNA2D2—epilepsy syndrome	0.00103	0.00382	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—SLC1A1—epilepsy syndrome	0.00102	0.00378	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—SLC8A2—epilepsy syndrome	0.000992	0.00369	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNH1—epilepsy syndrome	0.000982	0.00365	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GABRG2—epilepsy syndrome	0.000982	0.00365	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GABRA5—epilepsy syndrome	0.000971	0.00361	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—KCNJ10—epilepsy syndrome	0.000971	0.00361	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—ABAT—epilepsy syndrome	0.000971	0.00361	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—CACNA1A—epilepsy syndrome	0.000971	0.00361	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GRIA4—epilepsy syndrome	0.000971	0.00361	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—SLC8A3—epilepsy syndrome	0.000946	0.00352	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—ARHGEF9—epilepsy syndrome	0.000931	0.00346	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—SLC17A7—epilepsy syndrome	0.000931	0.00346	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GABRA1—epilepsy syndrome	0.000931	0.00346	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GABRB3—epilepsy syndrome	0.000931	0.00346	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Platelet homeostasis—NOS2—epilepsy syndrome	0.000919	0.00341	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GLUL—epilepsy syndrome	0.000913	0.00339	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GRIA2—epilepsy syndrome	0.000896	0.00333	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—NOS1—epilepsy syndrome	0.000889	0.0033	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—SLC1A2—epilepsy syndrome	0.000866	0.00322	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GRIK1—epilepsy syndrome	0.000866	0.00322	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—CHRNA7—epilepsy syndrome	0.000866	0.00322	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GABRB2—epilepsy syndrome	0.000826	0.00307	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—SYN1—epilepsy syndrome	0.000823	0.00306	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—NSF—epilepsy syndrome	0.000823	0.00306	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.000814	0.00302	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—STXBP1—epilepsy syndrome	0.0008	0.00297	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—SLC1A1—epilepsy syndrome	0.00078	0.0029	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—ABAT—epilepsy syndrome	0.000744	0.00276	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNJ10—epilepsy syndrome	0.000744	0.00276	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GRIA4—epilepsy syndrome	0.000744	0.00276	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CACNA1A—epilepsy syndrome	0.000744	0.00276	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GABRA5—epilepsy syndrome	0.000744	0.00276	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000736	0.00273	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000736	0.00273	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—TEK—epilepsy syndrome	0.000717	0.00266	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—TEK—epilepsy syndrome	0.000717	0.00266	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—ARHGEF9—epilepsy syndrome	0.000713	0.00265	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—SLC17A7—epilepsy syndrome	0.000713	0.00265	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GABRA1—epilepsy syndrome	0.000713	0.00265	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GABRB3—epilepsy syndrome	0.000713	0.00265	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000706	0.00262	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GLUL—epilepsy syndrome	0.0007	0.0026	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GRIA2—epilepsy syndrome	0.000687	0.00255	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—FLNA—epilepsy syndrome	0.000674	0.00251	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—FLNA—epilepsy syndrome	0.000674	0.00251	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.000673	0.0025	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—SLC1A2—epilepsy syndrome	0.000663	0.00246	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CHRNA7—epilepsy syndrome	0.000663	0.00246	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GRIK1—epilepsy syndrome	0.000663	0.00246	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP2C19—epilepsy syndrome	0.00066	0.00245	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000656	0.00244	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000656	0.00244	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000656	0.00244	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP11A1—epilepsy syndrome	0.000656	0.00244	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—YWHAZ—epilepsy syndrome	0.00065	0.00242	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—KCNMA1—epilepsy syndrome	0.000639	0.00237	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—KCNMA1—epilepsy syndrome	0.000639	0.00237	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—TEK—epilepsy syndrome	0.000639	0.00237	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GABRB2—epilepsy syndrome	0.000633	0.00235	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—SLC8A1—epilepsy syndrome	0.000631	0.00235	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—SLC8A1—epilepsy syndrome	0.000631	0.00235	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GAD2—epilepsy syndrome	0.000624	0.00232	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.000621	0.00231	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—FLNA—epilepsy syndrome	0.000601	0.00223	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP2D6—epilepsy syndrome	0.000592	0.0022	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNMA1—epilepsy syndrome	0.000591	0.0022	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—KCNMA1—epilepsy syndrome	0.00057	0.00212	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000564	0.0021	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—SLC1A3—epilepsy syndrome	0.000564	0.0021	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNJ11—epilepsy syndrome	0.000564	0.0021	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GRIK2—epilepsy syndrome	0.000564	0.0021	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—SLC8A1—epilepsy syndrome	0.000563	0.00209	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	0.000546	0.00203	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GAD1—epilepsy syndrome	0.000541	0.00201	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—PRKCB—epilepsy syndrome	0.000537	0.00199	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PPIA—epilepsy syndrome	0.00053	0.00197	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PPIA—epilepsy syndrome	0.00053	0.00197	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GABBR1—epilepsy syndrome	0.000516	0.00192	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GRIA1—epilepsy syndrome	0.000503	0.00187	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—SLC6A1—epilepsy syndrome	0.000503	0.00187	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GRIN2A—epilepsy syndrome	0.000503	0.00187	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000497	0.00185	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—FOS—epilepsy syndrome	0.00049	0.00182	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000485	0.0018	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ATP2A2—epilepsy syndrome	0.000484	0.0018	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ATP2A2—epilepsy syndrome	0.000484	0.0018	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CHRNB2—epilepsy syndrome	0.000476	0.00177	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.000474	0.00176	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PPIA—epilepsy syndrome	0.000473	0.00176	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ITGA2—epilepsy syndrome	0.00047	0.00175	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITGA2—epilepsy syndrome	0.00047	0.00175	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.000469	0.00174	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CA13—epilepsy syndrome	0.000451	0.00168	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—CHRNA4—epilepsy syndrome	0.000432	0.00161	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ATP2A2—epilepsy syndrome	0.000432	0.0016	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ITGA2—epilepsy syndrome	0.000419	0.00156	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ADRA2A—epilepsy syndrome	0.000414	0.00154	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ADRA2A—epilepsy syndrome	0.000414	0.00154	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PLAT—epilepsy syndrome	0.000412	0.00153	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PLAT—epilepsy syndrome	0.000412	0.00153	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—NOS1—epilepsy syndrome	0.000387	0.00144	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—NOS1—epilepsy syndrome	0.000387	0.00144	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—BCHE—epilepsy syndrome	0.000381	0.00142	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—DLG4—epilepsy syndrome	0.000372	0.00138	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ADRA2A—epilepsy syndrome	0.000369	0.00137	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PLAT—epilepsy syndrome	0.000367	0.00136	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GRIN2B—epilepsy syndrome	0.000363	0.00135	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—epilepsy syndrome	0.000363	0.00135	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—AKT3—epilepsy syndrome	0.000363	0.00135	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—AKT3—epilepsy syndrome	0.000363	0.00135	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—PLCB1—epilepsy syndrome	0.000359	0.00134	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PLAUR—epilepsy syndrome	0.000358	0.00133	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PLAUR—epilepsy syndrome	0.000358	0.00133	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—JUN—epilepsy syndrome	0.000352	0.00131	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—NOS1—epilepsy syndrome	0.000345	0.00128	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PDXK—epilepsy syndrome	0.000342	0.00127	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CERS1—epilepsy syndrome	0.000342	0.00127	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—FAR1—epilepsy syndrome	0.000342	0.00127	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ADK—epilepsy syndrome	0.000342	0.00127	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—L2HGDH—epilepsy syndrome	0.000342	0.00127	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GLUD1—epilepsy syndrome	0.000342	0.00127	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CDC42—epilepsy syndrome	0.000331	0.00123	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—CDC42—epilepsy syndrome	0.000331	0.00123	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—AKT3—epilepsy syndrome	0.000323	0.0012	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PLAUR—epilepsy syndrome	0.000319	0.00119	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PNPO—epilepsy syndrome	0.000313	0.00116	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NHLRC1—epilepsy syndrome	0.000313	0.00116	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—EPM2A—epilepsy syndrome	0.000313	0.00116	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GAMT—epilepsy syndrome	0.000313	0.00116	CbGpPWpGaD
Nitroglycerin—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000296	0.000516	CcSEcCtD
Nitroglycerin—Pruritus—Diazepam—epilepsy syndrome	0.000296	0.000516	CcSEcCtD
Nitroglycerin—Rash—Propofol—epilepsy syndrome	0.000295	0.000514	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—CDC42—epilepsy syndrome	0.000295	0.0011	CbGpPWpGaD
Nitroglycerin—Dermatitis—Propofol—epilepsy syndrome	0.000295	0.000514	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—FYN—epilepsy syndrome	0.000295	0.00109	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—FYN—epilepsy syndrome	0.000295	0.00109	CbGpPWpGaD
Nitroglycerin—Immune system disorder—Gabapentin—epilepsy syndrome	0.000293	0.000511	CcSEcCtD
Nitroglycerin—Headache—Propofol—epilepsy syndrome	0.000293	0.000511	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000293	0.00051	CcSEcCtD
Nitroglycerin—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000292	0.000509	CcSEcCtD
Nitroglycerin—Vomiting—Midazolam—epilepsy syndrome	0.000291	0.000507	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CA4—epilepsy syndrome	0.000291	0.00108	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—QDPR—epilepsy syndrome	0.000291	0.00108	CbGpPWpGaD
Nitroglycerin—Asthenia—Felbamate—epilepsy syndrome	0.000291	0.000507	CcSEcCtD
Nitroglycerin—Vision blurred—Pregabalin—epilepsy syndrome	0.000291	0.000506	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—POMC—epilepsy syndrome	0.00029	0.00108	CbGpPWpGaD
Nitroglycerin—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000289	0.000503	CcSEcCtD
Nitroglycerin—Rash—Midazolam—epilepsy syndrome	0.000289	0.000503	CcSEcCtD
Nitroglycerin—Dizziness—Fosphenytoin—epilepsy syndrome	0.000289	0.000503	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000288	0.000502	CcSEcCtD
Nitroglycerin—Dermatitis—Midazolam—epilepsy syndrome	0.000288	0.000502	CcSEcCtD
Nitroglycerin—Urticaria—Carbamazepine—epilepsy syndrome	0.000288	0.000502	CcSEcCtD
Nitroglycerin—Vomiting—Levetiracetam—epilepsy syndrome	0.000287	0.000501	CcSEcCtD
Nitroglycerin—Headache—Midazolam—epilepsy syndrome	0.000287	0.0005	CcSEcCtD
Nitroglycerin—Pruritus—Felbamate—epilepsy syndrome	0.000287	0.0005	CcSEcCtD
Nitroglycerin—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000287	0.000499	CcSEcCtD
Nitroglycerin—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000287	0.000499	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000286	0.000499	CcSEcCtD
Nitroglycerin—Rash—Levetiracetam—epilepsy syndrome	0.000285	0.000497	CcSEcCtD
Nitroglycerin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000285	0.000496	CcSEcCtD
Nitroglycerin—Asthenia—Zonisamide—epilepsy syndrome	0.000285	0.000496	CcSEcCtD
Nitroglycerin—Mental disorder—Gabapentin—epilepsy syndrome	0.000285	0.000496	CcSEcCtD
Nitroglycerin—Agitation—Pregabalin—epilepsy syndrome	0.000283	0.000494	CcSEcCtD
Nitroglycerin—Headache—Levetiracetam—epilepsy syndrome	0.000283	0.000493	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—YWHAZ—epilepsy syndrome	0.000283	0.00105	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—YWHAZ—epilepsy syndrome	0.000283	0.00105	CbGpPWpGaD
Nitroglycerin—Erythema—Gabapentin—epilepsy syndrome	0.000283	0.000493	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	0.000282	0.00105	CbGpPWpGaD
Nitroglycerin—Angioedema—Pregabalin—epilepsy syndrome	0.000282	0.000491	CcSEcCtD
Nitroglycerin—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000282	0.000491	CcSEcCtD
Nitroglycerin—Dizziness—Vigabatrin—epilepsy syndrome	0.000281	0.00049	CcSEcCtD
Nitroglycerin—Confusional state—Valproic Acid—epilepsy syndrome	0.000281	0.000489	CcSEcCtD
Nitroglycerin—Pruritus—Zonisamide—epilepsy syndrome	0.000281	0.000489	CcSEcCtD
Nitroglycerin—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00028	0.000487	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000278	0.000485	CcSEcCtD
Nitroglycerin—Urticaria—Lamotrigine—epilepsy syndrome	0.000278	0.000485	CcSEcCtD
Nitroglycerin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000278	0.000485	CcSEcCtD
Nitroglycerin—Bradycardia—Topiramate—epilepsy syndrome	0.000278	0.000485	CcSEcCtD
Nitroglycerin—Nausea—Propofol—epilepsy syndrome	0.000278	0.000484	CcSEcCtD
Nitroglycerin—Vomiting—Fosphenytoin—epilepsy syndrome	0.000277	0.000483	CcSEcCtD
Nitroglycerin—Vertigo—Pregabalin—epilepsy syndrome	0.000277	0.000483	CcSEcCtD
Nitroglycerin—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000277	0.000483	CcSEcCtD
Nitroglycerin—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000277	0.000483	CcSEcCtD
Nitroglycerin—Dizziness—Diazepam—epilepsy syndrome	0.000277	0.000482	CcSEcCtD
Nitroglycerin—Infection—Valproic Acid—epilepsy syndrome	0.000277	0.000482	CcSEcCtD
Nitroglycerin—Syncope—Pregabalin—epilepsy syndrome	0.000277	0.000482	CcSEcCtD
Nitroglycerin—Rash—Fosphenytoin—epilepsy syndrome	0.000275	0.000479	CcSEcCtD
Nitroglycerin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000275	0.000479	CcSEcCtD
Nitroglycerin—Asthenia—Clonazepam—epilepsy syndrome	0.000274	0.000478	CcSEcCtD
Nitroglycerin—Rhinitis—Topiramate—epilepsy syndrome	0.000274	0.000477	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—COX3—epilepsy syndrome	0.000273	0.00102	CbGpPWpGaD
Nitroglycerin—Headache—Fosphenytoin—epilepsy syndrome	0.000273	0.000476	CcSEcCtD
Nitroglycerin—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000273	0.000476	CcSEcCtD
Nitroglycerin—Palpitations—Pregabalin—epilepsy syndrome	0.000273	0.000475	CcSEcCtD
Nitroglycerin—Asthenia—Phenytoin—epilepsy syndrome	0.000272	0.000475	CcSEcCtD
Nitroglycerin—Nausea—Midazolam—epilepsy syndrome	0.000272	0.000474	CcSEcCtD
Nitroglycerin—Tachycardia—Valproic Acid—epilepsy syndrome	0.000272	0.000473	CcSEcCtD
Nitroglycerin—Pharyngitis—Topiramate—epilepsy syndrome	0.000271	0.000473	CcSEcCtD
Nitroglycerin—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000271	0.000472	CcSEcCtD
Nitroglycerin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000271	0.000472	CcSEcCtD
Nitroglycerin—Pruritus—Clonazepam—epilepsy syndrome	0.00027	0.000471	CcSEcCtD
Nitroglycerin—Vomiting—Vigabatrin—epilepsy syndrome	0.00027	0.000471	CcSEcCtD
Nitroglycerin—Skin disorder—Valproic Acid—epilepsy syndrome	0.00027	0.000471	CcSEcCtD
Nitroglycerin—Oedema peripheral—Topiramate—epilepsy syndrome	0.000269	0.000469	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000269	0.000469	CcSEcCtD
Nitroglycerin—Pruritus—Phenytoin—epilepsy syndrome	0.000269	0.000468	CcSEcCtD
Nitroglycerin—Nausea—Levetiracetam—epilepsy syndrome	0.000269	0.000468	CcSEcCtD
Nitroglycerin—Rash—Vigabatrin—epilepsy syndrome	0.000268	0.000467	CcSEcCtD
Nitroglycerin—Dizziness—Felbamate—epilepsy syndrome	0.000268	0.000467	CcSEcCtD
Nitroglycerin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000268	0.000467	CcSEcCtD
Nitroglycerin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000267	0.000466	CcSEcCtD
Nitroglycerin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000267	0.000465	CcSEcCtD
Nitroglycerin—Vision blurred—Gabapentin—epilepsy syndrome	0.000266	0.000464	CcSEcCtD
Nitroglycerin—Headache—Vigabatrin—epilepsy syndrome	0.000266	0.000464	CcSEcCtD
Nitroglycerin—Vomiting—Diazepam—epilepsy syndrome	0.000266	0.000464	CcSEcCtD
Nitroglycerin—Rash—Diazepam—epilepsy syndrome	0.000264	0.00046	CcSEcCtD
Nitroglycerin—Dermatitis—Diazepam—epilepsy syndrome	0.000264	0.00046	CcSEcCtD
Nitroglycerin—Visual impairment—Topiramate—epilepsy syndrome	0.000263	0.000459	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—FYN—epilepsy syndrome	0.000263	0.000975	CbGpPWpGaD
Nitroglycerin—Dizziness—Zonisamide—epilepsy syndrome	0.000262	0.000457	CcSEcCtD
Nitroglycerin—Headache—Diazepam—epilepsy syndrome	0.000262	0.000457	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000261	0.000454	CcSEcCtD
Nitroglycerin—Hypotension—Valproic Acid—epilepsy syndrome	0.00026	0.000453	CcSEcCtD
Nitroglycerin—Asthenia—Carbamazepine—epilepsy syndrome	0.00026	0.000453	CcSEcCtD
Nitroglycerin—Agitation—Gabapentin—epilepsy syndrome	0.00026	0.000453	CcSEcCtD
Nitroglycerin—Nausea—Fosphenytoin—epilepsy syndrome	0.000259	0.000452	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—PFKL—epilepsy syndrome	0.000259	0.000963	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SLCO1A2—epilepsy syndrome	0.000259	0.000963	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SLC6A8—epilepsy syndrome	0.000259	0.000963	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CACNA2D2—epilepsy syndrome	0.000259	0.000963	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—KCNB1—epilepsy syndrome	0.000259	0.000963	CbGpPWpGaD
Nitroglycerin—Angioedema—Gabapentin—epilepsy syndrome	0.000258	0.00045	CcSEcCtD
Nitroglycerin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000258	0.00045	CcSEcCtD
Nitroglycerin—Vomiting—Felbamate—epilepsy syndrome	0.000258	0.000449	CcSEcCtD
Nitroglycerin—Pruritus—Carbamazepine—epilepsy syndrome	0.000256	0.000447	CcSEcCtD
Nitroglycerin—Rash—Felbamate—epilepsy syndrome	0.000256	0.000445	CcSEcCtD
Nitroglycerin—Dermatitis—Felbamate—epilepsy syndrome	0.000255	0.000445	CcSEcCtD
Nitroglycerin—Vertigo—Gabapentin—epilepsy syndrome	0.000254	0.000443	CcSEcCtD
Nitroglycerin—Headache—Felbamate—epilepsy syndrome	0.000254	0.000442	CcSEcCtD
Nitroglycerin—Confusional state—Pregabalin—epilepsy syndrome	0.000254	0.000442	CcSEcCtD
Nitroglycerin—Flushing—Topiramate—epilepsy syndrome	0.000254	0.000442	CcSEcCtD
Nitroglycerin—Cardiac disorder—Topiramate—epilepsy syndrome	0.000254	0.000442	CcSEcCtD
Nitroglycerin—Syncope—Gabapentin—epilepsy syndrome	0.000254	0.000442	CcSEcCtD
Nitroglycerin—Dizziness—Clonazepam—epilepsy syndrome	0.000253	0.00044	CcSEcCtD
Nitroglycerin—Nausea—Vigabatrin—epilepsy syndrome	0.000253	0.00044	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—YWHAZ—epilepsy syndrome	0.000252	0.000938	CbGpPWpGaD
Nitroglycerin—Vomiting—Zonisamide—epilepsy syndrome	0.000252	0.000439	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000252	0.000439	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—PLAU—epilepsy syndrome	0.000251	0.000934	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PLAU—epilepsy syndrome	0.000251	0.000934	CbGpPWpGaD
Nitroglycerin—Asthenia—Lamotrigine—epilepsy syndrome	0.000251	0.000438	CcSEcCtD
Nitroglycerin—Dizziness—Phenytoin—epilepsy syndrome	0.000251	0.000438	CcSEcCtD
Nitroglycerin—Rash—Zonisamide—epilepsy syndrome	0.00025	0.000436	CcSEcCtD
Nitroglycerin—Infection—Pregabalin—epilepsy syndrome	0.00025	0.000436	CcSEcCtD
Nitroglycerin—Paraesthesia—Valproic Acid—epilepsy syndrome	0.00025	0.000436	CcSEcCtD
Nitroglycerin—Palpitations—Gabapentin—epilepsy syndrome	0.00025	0.000435	CcSEcCtD
Nitroglycerin—Dermatitis—Zonisamide—epilepsy syndrome	0.00025	0.000435	CcSEcCtD
Nitroglycerin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00025	0.000435	CcSEcCtD
Nitroglycerin—Nausea—Diazepam—epilepsy syndrome	0.000249	0.000433	CcSEcCtD
Nitroglycerin—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000249	0.000433	CcSEcCtD
Nitroglycerin—Headache—Zonisamide—epilepsy syndrome	0.000249	0.000433	CcSEcCtD
Nitroglycerin—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000248	0.000432	CcSEcCtD
Nitroglycerin—Angiopathy—Topiramate—epilepsy syndrome	0.000248	0.000432	CcSEcCtD
Nitroglycerin—Pruritus—Lamotrigine—epilepsy syndrome	0.000248	0.000432	CcSEcCtD
Nitroglycerin—Shock—Pregabalin—epilepsy syndrome	0.000248	0.000431	CcSEcCtD
Nitroglycerin—Somnolence—Valproic Acid—epilepsy syndrome	0.000247	0.000431	CcSEcCtD
Nitroglycerin—Immune system disorder—Topiramate—epilepsy syndrome	0.000247	0.00043	CcSEcCtD
Nitroglycerin—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000247	0.00043	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000246	0.000429	CcSEcCtD
Nitroglycerin—Tachycardia—Pregabalin—epilepsy syndrome	0.000246	0.000428	CcSEcCtD
Nitroglycerin—Skin disorder—Pregabalin—epilepsy syndrome	0.000244	0.000426	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000243	0.000424	CcSEcCtD
Nitroglycerin—Vomiting—Clonazepam—epilepsy syndrome	0.000243	0.000424	CcSEcCtD
Nitroglycerin—Vomiting—Phenytoin—epilepsy syndrome	0.000241	0.000421	CcSEcCtD
Nitroglycerin—Rash—Clonazepam—epilepsy syndrome	0.000241	0.00042	CcSEcCtD
Nitroglycerin—Dermatitis—Clonazepam—epilepsy syndrome	0.000241	0.00042	CcSEcCtD
Nitroglycerin—Nausea—Felbamate—epilepsy syndrome	0.000241	0.000419	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.00024	0.000419	CcSEcCtD
Nitroglycerin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.00024	0.000418	CcSEcCtD
Nitroglycerin—Dizziness—Carbamazepine—epilepsy syndrome	0.00024	0.000418	CcSEcCtD
Nitroglycerin—Headache—Clonazepam—epilepsy syndrome	0.00024	0.000417	CcSEcCtD
Nitroglycerin—Rash—Phenytoin—epilepsy syndrome	0.000239	0.000417	CcSEcCtD
Nitroglycerin—Mental disorder—Topiramate—epilepsy syndrome	0.000239	0.000417	CcSEcCtD
Nitroglycerin—Dermatitis—Phenytoin—epilepsy syndrome	0.000239	0.000417	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000239	0.000417	CcSEcCtD
Nitroglycerin—Rash—Oxcarbazepine—epilepsy syndrome	0.000238	0.000415	CcSEcCtD
Nitroglycerin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000238	0.000415	CcSEcCtD
Nitroglycerin—Headache—Phenytoin—epilepsy syndrome	0.000238	0.000414	CcSEcCtD
Nitroglycerin—Erythema—Topiramate—epilepsy syndrome	0.000238	0.000414	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—NEU1—epilepsy syndrome	0.000237	0.000881	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—UPB1—epilepsy syndrome	0.000237	0.000881	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ATIC—epilepsy syndrome	0.000237	0.000881	CbGpPWpGaD
Nitroglycerin—Headache—Oxcarbazepine—epilepsy syndrome	0.000237	0.000412	CcSEcCtD
Nitroglycerin—Nausea—Zonisamide—epilepsy syndrome	0.000236	0.000411	CcSEcCtD
Nitroglycerin—Hypotension—Pregabalin—epilepsy syndrome	0.000235	0.00041	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—PRKCB—epilepsy syndrome	0.000234	0.000868	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PRKCB—epilepsy syndrome	0.000234	0.000868	CbGpPWpGaD
Nitroglycerin—Confusional state—Gabapentin—epilepsy syndrome	0.000233	0.000405	CcSEcCtD
Nitroglycerin—Dizziness—Lamotrigine—epilepsy syndrome	0.000232	0.000404	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—NOS2—epilepsy syndrome	0.000231	0.000858	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—NOS2—epilepsy syndrome	0.000231	0.000858	CbGpPWpGaD
Nitroglycerin—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000231	0.000402	CcSEcCtD
Nitroglycerin—Vomiting—Carbamazepine—epilepsy syndrome	0.00023	0.000402	CcSEcCtD
Nitroglycerin—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000229	0.0004	CcSEcCtD
Nitroglycerin—Infection—Gabapentin—epilepsy syndrome	0.000229	0.000399	CcSEcCtD
Nitroglycerin—Rash—Carbamazepine—epilepsy syndrome	0.000229	0.000398	CcSEcCtD
Nitroglycerin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000228	0.000398	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—HSD17B4—epilepsy syndrome	0.000228	0.000848	CbGpPWpGaD
Nitroglycerin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000228	0.000397	CcSEcCtD
Nitroglycerin—Nausea—Clonazepam—epilepsy syndrome	0.000227	0.000396	CcSEcCtD
Nitroglycerin—Headache—Carbamazepine—epilepsy syndrome	0.000227	0.000396	CcSEcCtD
Nitroglycerin—Shock—Gabapentin—epilepsy syndrome	0.000227	0.000396	CcSEcCtD
Nitroglycerin—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000226	0.000394	CcSEcCtD
Nitroglycerin—Paraesthesia—Pregabalin—epilepsy syndrome	0.000226	0.000394	CcSEcCtD
Nitroglycerin—Nausea—Phenytoin—epilepsy syndrome	0.000226	0.000393	CcSEcCtD
Nitroglycerin—Tachycardia—Gabapentin—epilepsy syndrome	0.000225	0.000392	CcSEcCtD
Nitroglycerin—Dyspnoea—Pregabalin—epilepsy syndrome	0.000224	0.000391	CcSEcCtD
Nitroglycerin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000224	0.000391	CcSEcCtD
Nitroglycerin—Vision blurred—Topiramate—epilepsy syndrome	0.000224	0.000391	CcSEcCtD
Nitroglycerin—Skin disorder—Gabapentin—epilepsy syndrome	0.000224	0.000391	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PLAU—epilepsy syndrome	0.000224	0.000832	CbGpPWpGaD
Nitroglycerin—Somnolence—Pregabalin—epilepsy syndrome	0.000224	0.00039	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000223	0.000389	CcSEcCtD
Nitroglycerin—Vomiting—Lamotrigine—epilepsy syndrome	0.000223	0.000388	CcSEcCtD
Nitroglycerin—Urticaria—Valproic Acid—epilepsy syndrome	0.000221	0.000385	CcSEcCtD
Nitroglycerin—Rash—Lamotrigine—epilepsy syndrome	0.000221	0.000385	CcSEcCtD
Nitroglycerin—Dermatitis—Lamotrigine—epilepsy syndrome	0.000221	0.000385	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—PPP1R3C—epilepsy syndrome	0.00022	0.000819	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GBE1—epilepsy syndrome	0.00022	0.000819	CbGpPWpGaD
Nitroglycerin—Abdominal pain—Valproic Acid—epilepsy syndrome	0.00022	0.000383	CcSEcCtD
Nitroglycerin—Body temperature increased—Valproic Acid—epilepsy syndrome	0.00022	0.000383	CcSEcCtD
Nitroglycerin—Headache—Lamotrigine—epilepsy syndrome	0.000219	0.000382	CcSEcCtD
Nitroglycerin—Agitation—Topiramate—epilepsy syndrome	0.000219	0.000381	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000217	0.000379	CcSEcCtD
Nitroglycerin—ALDH2—Neuronal System—PRKCB—epilepsy syndrome	0.000216	0.000803	CbGpPWpGaD
Nitroglycerin—Hypotension—Gabapentin—epilepsy syndrome	0.000216	0.000376	CcSEcCtD
Nitroglycerin—Nausea—Carbamazepine—epilepsy syndrome	0.000215	0.000375	CcSEcCtD
Nitroglycerin—Vertigo—Topiramate—epilepsy syndrome	0.000214	0.000372	CcSEcCtD
Nitroglycerin—Syncope—Topiramate—epilepsy syndrome	0.000213	0.000372	CcSEcCtD
Nitroglycerin—Palpitations—Topiramate—epilepsy syndrome	0.00021	0.000366	CcSEcCtD
Nitroglycerin—Loss of consciousness—Topiramate—epilepsy syndrome	0.000209	0.000364	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PRKCB—epilepsy syndrome	0.000208	0.000774	CbGpPWpGaD
Nitroglycerin—Nausea—Lamotrigine—epilepsy syndrome	0.000208	0.000363	CcSEcCtD
Nitroglycerin—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000207	0.000361	CcSEcCtD
Nitroglycerin—Paraesthesia—Gabapentin—epilepsy syndrome	0.000207	0.000361	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ASAH1—epilepsy syndrome	0.000207	0.00077	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—NOS2—epilepsy syndrome	0.000206	0.000765	CbGpPWpGaD
Nitroglycerin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000206	0.000359	CcSEcCtD
Nitroglycerin—Dyspnoea—Gabapentin—epilepsy syndrome	0.000206	0.000358	CcSEcCtD
Nitroglycerin—Somnolence—Gabapentin—epilepsy syndrome	0.000205	0.000357	CcSEcCtD
Nitroglycerin—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000205	0.000357	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—STXBP1—epilepsy syndrome	0.000202	0.000749	CbGpPWpGaD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000201	0.00035	CcSEcCtD
Nitroglycerin—Urticaria—Pregabalin—epilepsy syndrome	0.0002	0.000348	CcSEcCtD
Nitroglycerin—Asthenia—Valproic Acid—epilepsy syndrome	0.0002	0.000348	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000199	0.000347	CcSEcCtD
Nitroglycerin—Abdominal pain—Pregabalin—epilepsy syndrome	0.000199	0.000347	CcSEcCtD
Nitroglycerin—Body temperature increased—Pregabalin—epilepsy syndrome	0.000199	0.000347	CcSEcCtD
Nitroglycerin—Pruritus—Valproic Acid—epilepsy syndrome	0.000197	0.000343	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ALAD—epilepsy syndrome	0.000196	0.00073	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NT5E—epilepsy syndrome	0.000196	0.00073	CbGpPWpGaD
Nitroglycerin—Confusional state—Topiramate—epilepsy syndrome	0.000196	0.000341	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—ALB—epilepsy syndrome	0.000194	0.000721	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ALB—epilepsy syndrome	0.000194	0.000721	CbGpPWpGaD
Nitroglycerin—Infection—Topiramate—epilepsy syndrome	0.000193	0.000336	CcSEcCtD
Nitroglycerin—Shock—Topiramate—epilepsy syndrome	0.000191	0.000333	CcSEcCtD
Nitroglycerin—Nervous system disorder—Topiramate—epilepsy syndrome	0.00019	0.000332	CcSEcCtD
Nitroglycerin—Feeling abnormal—Gabapentin—epilepsy syndrome	0.00019	0.000331	CcSEcCtD
Nitroglycerin—Tachycardia—Topiramate—epilepsy syndrome	0.000189	0.00033	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000189	0.000329	CcSEcCtD
Nitroglycerin—Skin disorder—Topiramate—epilepsy syndrome	0.000189	0.000329	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000188	0.000327	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CACNA1A—epilepsy syndrome	0.000187	0.000696	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ALDH7A1—epilepsy syndrome	0.000187	0.000696	CbGpPWpGaD
Nitroglycerin—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000185	0.000323	CcSEcCtD
Nitroglycerin—Dizziness—Valproic Acid—epilepsy syndrome	0.000184	0.000321	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ST3GAL3—epilepsy syndrome	0.000183	0.000681	CbGpPWpGaD
Nitroglycerin—Urticaria—Gabapentin—epilepsy syndrome	0.000183	0.000319	CcSEcCtD
Nitroglycerin—Body temperature increased—Gabapentin—epilepsy syndrome	0.000182	0.000318	CcSEcCtD
Nitroglycerin—Abdominal pain—Gabapentin—epilepsy syndrome	0.000182	0.000318	CcSEcCtD
Nitroglycerin—Hypotension—Topiramate—epilepsy syndrome	0.000181	0.000316	CcSEcCtD
Nitroglycerin—Asthenia—Pregabalin—epilepsy syndrome	0.000181	0.000315	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ADSL—epilepsy syndrome	0.00018	0.000667	CbGpPWpGaD
Nitroglycerin—Pruritus—Pregabalin—epilepsy syndrome	0.000178	0.00031	CcSEcCtD
Nitroglycerin—Vomiting—Valproic Acid—epilepsy syndrome	0.000177	0.000308	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GLUL—epilepsy syndrome	0.000176	0.000655	CbGpPWpGaD
Nitroglycerin—Rash—Valproic Acid—epilepsy syndrome	0.000176	0.000306	CcSEcCtD
Nitroglycerin—Dermatitis—Valproic Acid—epilepsy syndrome	0.000175	0.000306	CcSEcCtD
Nitroglycerin—Headache—Valproic Acid—epilepsy syndrome	0.000174	0.000304	CcSEcCtD
Nitroglycerin—Paraesthesia—Topiramate—epilepsy syndrome	0.000174	0.000304	CcSEcCtD
Nitroglycerin—Dyspnoea—Topiramate—epilepsy syndrome	0.000173	0.000302	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—ALB—epilepsy syndrome	0.000173	0.000643	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CACNA1D—epilepsy syndrome	0.000173	0.000642	CbGpPWpGaD
Nitroglycerin—Somnolence—Topiramate—epilepsy syndrome	0.000173	0.000301	CcSEcCtD
Nitroglycerin—Hypersensitivity—Gabapentin—epilepsy syndrome	0.00017	0.000296	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000168	0.000292	CcSEcCtD
Nitroglycerin—Dizziness—Pregabalin—epilepsy syndrome	0.000166	0.00029	CcSEcCtD
Nitroglycerin—Asthenia—Gabapentin—epilepsy syndrome	0.000166	0.000288	CcSEcCtD
Nitroglycerin—Nausea—Valproic Acid—epilepsy syndrome	0.000165	0.000288	CcSEcCtD
Nitroglycerin—Pruritus—Gabapentin—epilepsy syndrome	0.000163	0.000284	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—TXNRD1—epilepsy syndrome	0.000162	0.000601	CbGpPWpGaD
Nitroglycerin—Vomiting—Pregabalin—epilepsy syndrome	0.00016	0.000279	CcSEcCtD
Nitroglycerin—Feeling abnormal—Topiramate—epilepsy syndrome	0.00016	0.000279	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000159	0.000277	CcSEcCtD
Nitroglycerin—Rash—Pregabalin—epilepsy syndrome	0.000159	0.000276	CcSEcCtD
Nitroglycerin—Dermatitis—Pregabalin—epilepsy syndrome	0.000159	0.000276	CcSEcCtD
Nitroglycerin—Headache—Pregabalin—epilepsy syndrome	0.000158	0.000275	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—AQP1—epilepsy syndrome	0.000157	0.000583	CbGpPWpGaD
Nitroglycerin—Urticaria—Topiramate—epilepsy syndrome	0.000154	0.000269	CcSEcCtD
Nitroglycerin—Body temperature increased—Topiramate—epilepsy syndrome	0.000153	0.000267	CcSEcCtD
Nitroglycerin—Abdominal pain—Topiramate—epilepsy syndrome	0.000153	0.000267	CcSEcCtD
Nitroglycerin—Dizziness—Gabapentin—epilepsy syndrome	0.000153	0.000266	CcSEcCtD
Nitroglycerin—Nausea—Pregabalin—epilepsy syndrome	0.000149	0.00026	CcSEcCtD
Nitroglycerin—Vomiting—Gabapentin—epilepsy syndrome	0.000147	0.000256	CcSEcCtD
Nitroglycerin—Rash—Gabapentin—epilepsy syndrome	0.000146	0.000254	CcSEcCtD
Nitroglycerin—Dermatitis—Gabapentin—epilepsy syndrome	0.000145	0.000253	CcSEcCtD
Nitroglycerin—Headache—Gabapentin—epilepsy syndrome	0.000145	0.000252	CcSEcCtD
Nitroglycerin—Hypersensitivity—Topiramate—epilepsy syndrome	0.000143	0.000249	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—KCNJ11—epilepsy syndrome	0.000142	0.000528	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CHRM3—epilepsy syndrome	0.000142	0.000528	CbGpPWpGaD
Nitroglycerin—Asthenia—Topiramate—epilepsy syndrome	0.000139	0.000243	CcSEcCtD
Nitroglycerin—Pruritus—Topiramate—epilepsy syndrome	0.000137	0.000239	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—SRC—epilepsy syndrome	0.000137	0.00051	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—SRC—epilepsy syndrome	0.000137	0.00051	CbGpPWpGaD
Nitroglycerin—Nausea—Gabapentin—epilepsy syndrome	0.000137	0.000239	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—VEGFA—epilepsy syndrome	0.000134	0.000497	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—VEGFA—epilepsy syndrome	0.000134	0.000497	CbGpPWpGaD
Nitroglycerin—Dizziness—Topiramate—epilepsy syndrome	0.000128	0.000224	CcSEcCtD
Nitroglycerin—Vomiting—Topiramate—epilepsy syndrome	0.000123	0.000215	CcSEcCtD
Nitroglycerin—Rash—Topiramate—epilepsy syndrome	0.000122	0.000213	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—SRC—epilepsy syndrome	0.000122	0.000455	CbGpPWpGaD
Nitroglycerin—Dermatitis—Topiramate—epilepsy syndrome	0.000122	0.000213	CcSEcCtD
Nitroglycerin—Headache—Topiramate—epilepsy syndrome	0.000122	0.000212	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—VEGFA—epilepsy syndrome	0.000119	0.000443	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ABCG2—epilepsy syndrome	0.000116	0.00043	CbGpPWpGaD
Nitroglycerin—Nausea—Topiramate—epilepsy syndrome	0.000115	0.000201	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CYP2C19—epilepsy syndrome	0.000113	0.000419	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP11A1—epilepsy syndrome	0.000112	0.000417	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP2D6—epilepsy syndrome	0.000101	0.000376	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ADRA2A—epilepsy syndrome	9.63e-05	0.000358	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—BCHE—epilepsy syndrome	9.59e-05	0.000356	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SLC2A1—epilepsy syndrome	9.15e-05	0.00034	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PLCB1—epilepsy syndrome	9.05e-05	0.000336	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—TH—epilepsy syndrome	9.02e-05	0.000335	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—AKT1—epilepsy syndrome	8.53e-05	0.000317	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—AKT1—epilepsy syndrome	8.53e-05	0.000317	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—AKT1—epilepsy syndrome	7.61e-05	0.000283	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HMOX1—epilepsy syndrome	7.53e-05	0.00028	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CAT—epilepsy syndrome	7.43e-05	0.000276	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ABCB1—epilepsy syndrome	7.22e-05	0.000268	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GPX1—epilepsy syndrome	6.72e-05	0.00025	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—AGT—epilepsy syndrome	5.89e-05	0.000219	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—APOE—epilepsy syndrome	5.77e-05	0.000214	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—POMC—epilepsy syndrome	4.96e-05	0.000184	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ALB—epilepsy syndrome	4.52e-05	0.000168	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTGS2—epilepsy syndrome	3.95e-05	0.000147	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—AKT1—epilepsy syndrome	1.99e-05	7.38e-05	CbGpPWpGaD
